Overseas Drug Bribery Probes Turn to Drug Testing, Payments

March 13, 2019

Clinical trials, drug labeling, and payments for testing are all potential bribery pitfalls for medical device manufacturers and drug companies operating outside the U.S., and investigators are giving them closer scrutiny.

Related Stories